Dilemmas concerning dose distribution and the influence of relative biological effect in proton beam therapy of medulloblastoma.

The British Journal of Radiology
B JonesG McKenna

Abstract

To improve medulloblastoma proton therapy. Although considered ideal for proton therapy, there are potential disadvantages. Expected benefits include reduced radiation-induced cancer and circulatory complications, while avoiding small brain volumes of dose in-homogeneity when compared with conventional X-rays. Several aspects of proton therapy might contribute to reduced tumour control due to (a) the use of more homogenous dose levels which can result in under-dosage, (b) differences in relative biological effectiveness (RBE) between that prescription RBE of 1.1 and the RBE of brain and spinal cord (likely to exceed 1.1) and in medulloblastoma cells (where RBE is likely to be below 1.1). Such changes, although speculative for RBE, might result in potential underdosage of tumour cells and a higher bio-effect in brain tissue. Dose distributions for X-ray and proton treatment are compared, with allocation of likely RBE values for fast growing medullolastoma cells and stable central nervous system tissue. These physical and radiobiological factors are shown to combine to give a higher risk of tumour recurrence with further risks on tumour control when dose reduction schedules used for X-ray therapy are replicated for proton therapy...Continue Reading

References

Aug 1, 1996·International Journal of Radiation Oncology, Biology, Physics·E C Halperin
Sep 25, 1998·International Journal of Radiation Oncology, Biology, Physics·J O del CharcoR B Marcus
Jul 21, 2000·International Journal of Radiation Biology·M BelliP Tiveron
May 23, 2002·International Journal of Radiation Oncology, Biology, Physics·Harald PaganettiHerman D Suit
Oct 16, 2002·International Journal of Radiation Oncology, Biology, Physics·Raymond MiralbellUwe Schneider
Oct 8, 2003·Technology in Cancer Research & Treatment·H Paganetti
Feb 18, 2004·International Journal of Radiation Oncology, Biology, Physics·W H St ClairN J Tarbell
Sep 20, 2005·International Journal of Radiation Oncology, Biology, Physics·Catherine T LeeAlfred R Smith
Nov 22, 2007·International Journal of Radiation Oncology, Biology, Physics·David M CochranNancy J Tarbell
Mar 6, 2012·The British Journal of Radiology·B JonesR G Dale

❮ Previous
Next ❯

Citations

May 2, 2013·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·J L Lopez GuerraR Matute
Dec 11, 2013·Medical Physics·Rebecca GrünMichael Scholz
Feb 14, 2014·International Journal of Radiation Oncology, Biology, Physics·Roshan V SethiShannon M MacDonald
Sep 10, 2014·International Journal of Radiation Oncology, Biology, Physics·Bleddyn Jones
Jan 28, 2016·Journal of Medical Imaging and Radiation Oncology·Michael Jackson
Mar 12, 2013·Seminars in Radiation Oncology·Harald Paganetti, Peter van Luijk
Mar 12, 2013·Seminars in Radiation Oncology·Thomas E Merchant
Mar 12, 2013·Seminars in Radiation Oncology·Robert C MillerBleddyn Jones
Feb 3, 2016·The Lancet Oncology·David R Grosshans
Nov 10, 2015·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·A LaprieUNKNOWN radiotherapy committee of SFCE and France Hadron
May 16, 2015·Postgraduate Medical Journal·Samuel Swisher-McClureJustin Bekelman
Apr 4, 2015·International Journal of Radiation Oncology, Biology, Physics·Harald Paganetti
May 24, 2017·British Journal of Cancer·Pavel ChernyavskiyMark P Little
Mar 25, 2016·Nature Reviews. Cancer·Michael BaumannThomas Bortfeld
Jul 17, 2019·Medical Physics·Daniel Sánchez-ParcerisaJosé Manuel Udías
Aug 23, 2019·The British Journal of Radiology·Thomas Friedrich
Apr 4, 2017·Current Treatment Options in Neurology·Stephanie E Combs
Oct 30, 2018·International Journal of Particle Therapy·Harald Paganetti
Apr 12, 2020·Scientific Reports·Kristian S Ytre-HaugeCamilla H Stokkevåg
Sep 13, 2013·Physics in Medicine and Biology·T FriedrichM Scholz
Jan 29, 2021·International Journal of Radiation Oncology, Biology, Physics·Daniel J IndelicatoShannon M MacDonald
Feb 19, 2021·International Journal of Radiation Oncology, Biology, Physics·Ying Y ZhangAnnie W Chan
Mar 24, 2021·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Avani Dholakia RaoMark V Mishra
Aug 19, 2021·International Journal of Radiation Oncology, Biology, Physics·Harald Paganetti

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Radiation Oncology, Biology, Physics
Clemens GrassbergerHarald Paganetti
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
Anna Skowrońska-GardasMarta Perek-Polnik
© 2021 Meta ULC. All rights reserved